Hydroxychloroquine vs Pembrolizumab
Hydroxychloroquine vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Hydroxychloroquine and Pembrolizumab.
Mechanism of Action
Hydroxychloroquine: Accumulates in lysosomes raising pH; inhibits toll-like receptor signaling.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Hydroxychloroquine — 40-50 days; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Hydroxychloroquine — C18H26ClN3O.
Molecular Weight: Hydroxychloroquine — 335.8720 g/mol.
Type: Hydroxychloroquine — Small molecule; Pembrolizumab — Antibody.